Position in LLY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$5,266,697
+$1,259,260 QoQ
Shares Held
4,391
+0.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
2.37%
of 13F equity value
Holder Rank
#1,671
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Argent Advisors, Inc. holds $22,940,677 across 9 Drug Manufacturers - General names. LLY ranks #1 (23.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
4,391 | $5,266,697 | |
| 2 | JNJ |
Johnson & Johnson
|
20,074 | $5,098,193 | |
| 3 | MRK |
Merck & Co., Inc.
|
24,547 | $3,154,289 | |
| 4 | GSK |
GSK plc
|
51,943 | $2,722,852 | |
| 5 | PFE |
Pfizer Inc
|
109,643 | $2,640,203 | |
| 6 | AMGN |
Amgen Inc
|
4,586 | $1,660,682 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
11,701 | $1,478,304 | |
| 8 | ABBV |
AbbVie Inc.
|
2,592 | $652,250 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,266,697 | 4,391 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $4,007,437 | 4,357 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $4,772,654 | 4,441 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $3,245,802 | 4,254 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $3,304,427 | 4,239 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $3,505,987 | 4,245 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $3,057,892 | 3,961 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $3,580,083 | 4,041 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,663,167 | 4,046 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $3,155,405 | 4,056 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $2,376,564 | 4,077 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,195,250 | 4,087 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,892,803 | 4,036 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $1,411,799 | 4,111 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $1,511,285 | 4,131 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $1,465,098 | 4,531 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,469,085 | 4,531 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $1,297,542 | 4,531 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $1,251,552 | 4,531 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $1,046,887 | 4,531 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $1,065,202 | 4,641 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $903,461 | 4,836 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $488,454 | 2,893 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $645,959 | 4,364 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $726,332 | 4,424 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $634,089 | 4,571 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||